Global Rare Disease Genetic Testing Market Size, Status and Forecast 2020-2026


Rare Disease Genetic Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Rare Disease Genetic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
    Next-Generation Sequencing (NGS)
    Array Technology
    PCR-based Testing
    Fluorescence in Situ Hybridization (FISH)
    Sanger Sequencing
    Karyotyping
    Others

Market segment by Application, split into
    Research Laboratories and CROs
    Diagnostic Laboratories
    Hospitals and Clinics
    Others

Based on regional and country-level analysis, the Rare Disease Genetic Testing market has been segmented as follows:
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia-Pacific
    Latin America
        Mexico
        Brazil
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Rare Disease Genetic Testing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
    Quest Diagnostics
    Centogene
    Invitae Corporation
    3billion
    Arup Laboratories
    Eurofins Scientific
    Strand Life Sciences
    Ambry Genetics
    Perkin Elmer
    Macrogen
    Baylor Genetics
    Color Genomics
    Preventiongenetics
    Progenity
    Coopersurgical
    Fulgent Genetics
    Myriad Genetics
    LabCorp
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Rare Disease Genetic Testing Market Size Growth Rate by Type: 2020 VS 2026
        1.2.2 Next-Generation Sequencing (NGS)
        1.2.3 Array Technology
        1.2.4 PCR-based Testing
        1.2.5 Fluorescence in Situ Hybridization (FISH)
        1.2.6 Sanger Sequencing
        1.2.7 Karyotyping
        1.2.8 Others
    1.3 Market by Application
        1.3.1 Global Rare Disease Genetic Testing Market Share by Application: 2020 VS 2026
        1.3.2 Research Laboratories and CROs
        1.3.3 Diagnostic Laboratories
        1.3.4 Hospitals and Clinics
        1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
    2.1 Global Rare Disease Genetic Testing Market Perspective (2015-2026)
    2.2 Global Rare Disease Genetic Testing Growth Trends by Regions
        2.2.1 Rare Disease Genetic Testing Market Size by Regions: 2015 VS 2020 VS 2026
        2.2.2 Rare Disease Genetic Testing Historic Market Share by Regions (2015-2020)
        2.2.3 Rare Disease Genetic Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
        2.3.3 Market Challenges
        2.3.4 Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Rare Disease Genetic Testing Players by Market Size
        3.1.1 Global Top Rare Disease Genetic Testing Players by Revenue (2015-2020)
        3.1.2 Global Rare Disease Genetic Testing Revenue Market Share by Players (2015-2020)
    3.2 Global Rare Disease Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Rare Disease Genetic Testing Revenue
    3.4 Global Rare Disease Genetic Testing Market Concentration Ratio
        3.4.1 Global Rare Disease Genetic Testing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Rare Disease Genetic Testing Revenue in 2019
    3.5 Key Players Rare Disease Genetic Testing Area Served
    3.6 Key Players Rare Disease Genetic Testing Product Solution and Service
    3.7 Date of Enter into Rare Disease Genetic Testing Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Rare Disease Genetic Testing Breakdown Data by Type (2015-2026)
    4.1 Global Rare Disease Genetic Testing Historic Market Size by Type (2015-2020)
    4.2 Global Rare Disease Genetic Testing Forecasted Market Size by Type (2021-2026)

5 Rare Disease Genetic Testing Breakdown Data by Application (2015-2026)
    5.1 Global Rare Disease Genetic Testing Historic Market Size by Application (2015-2020)
    5.2 Global Rare Disease Genetic Testing Forecasted Market Size by Application (2021-2026)

6 North America
    6.1 North America Rare Disease Genetic Testing Market Size (2015-2026)
    6.2 North America Rare Disease Genetic Testing Market Size by Type (2015-2020)
    6.3 North America Rare Disease Genetic Testing Market Size by Application (2015-2020)
    6.4 North America Rare Disease Genetic Testing Market Size by Country (2015-2020)
        6.4.1 United States
        6.4.2 Canada

7 Europe
    7.1 Europe Rare Disease Genetic Testing Market Size (2015-2026)
    7.2 Europe Rare Disease Genetic Testing Market Size by Type (2015-2020)
    7.3 Europe Rare Disease Genetic Testing Market Size by Application (2015-2020)
    7.4 Europe Rare Disease Genetic Testing Market Size by Country (2015-2020)
        7.4.1 Germany
        7.4.2 France
        7.4.3 U.K.
        7.4.4 Italy
        7.4.5 Russia
        7.4.6 Nordic
        7.4.7 Rest of Europe

8 China
    8.1 China Rare Disease Genetic Testing Market Size (2015-2026)
    8.2 China Rare Disease Genetic Testing Market Size by Type (2015-2020)
    8.3 China Rare Disease Genetic Testing Market Size by Application (2015-2020)
    8.4 China Rare Disease Genetic Testing Market Size by Region (2015-2020)
        8.4.1 China
        8.4.2 Japan
        8.4.3 South Korea
        8.4.4 Southeast Asia
        8.4.5 India
        8.4.6 Australia
        8.4.7 Rest of Asia-Pacific

9 Japan
    9.1 Japan Rare Disease Genetic Testing Market Size (2015-2026)
    9.2 Japan Rare Disease Genetic Testing Market Size by Type (2015-2020)
    9.3 Japan Rare Disease Genetic Testing Market Size by Application (2015-2020)
    9.4 Japan Rare Disease Genetic Testing Market Size by Country (2015-2020)
        9.4.1 Mexico
        9.4.2 Brazil

10 Southeast Asia
    10.1 Southeast Asia Rare Disease Genetic Testing Market Size (2015-2026)
    10.2 Southeast Asia Rare Disease Genetic Testing Market Size by Type (2015-2020)
    10.3 Southeast Asia Rare Disease Genetic Testing Market Size by Application (2015-2020)
    10.4 Southeast Asia Rare Disease Genetic Testing Market Size by Country (2015-2020)
        10.4.1 Turkey
        10.4.2 Saudi Arabia
        10.4.3 UAE
        10.4.4 Rest of Middle East & Africa

11Key Players Profiles
    11.1 Quest Diagnostics
        11.1.1 Quest Diagnostics Company Details
        11.1.2 Quest Diagnostics Business Overview
        11.1.3 Quest Diagnostics Rare Disease Genetic Testing Introduction
        11.1.4 Quest Diagnostics Revenue in Rare Disease Genetic Testing Business (2015-2020))
        11.1.5 Quest Diagnostics Recent Development
    11.2 Centogene
        11.2.1 Centogene Company Details
        11.2.2 Centogene Business Overview
        11.2.3 Centogene Rare Disease Genetic Testing Introduction
        11.2.4 Centogene Revenue in Rare Disease Genetic Testing Business (2015-2020)
        11.2.5 Centogene Recent Development
    11.3 Invitae Corporation
        11.3.1 Invitae Corporation Company Details
        11.3.2 Invitae Corporation Business Overview
        11.3.3 Invitae Corporation Rare Disease Genetic Testing Introduction
        11.3.4 Invitae Corporation Revenue in Rare Disease Genetic Testing Business (2015-2020)
        11.3.5 Invitae Corporation Recent Development
    11.4 3billion
        11.4.1 3billion Company Details
        11.4.2 3billion Business Overview
        11.4.3 3billion Rare Disease Genetic Testing Introduction
        11.4.4 3billion Revenue in Rare Disease Genetic Testing Business (2015-2020)
        11.4.5 3billion Recent Development
    11.5 Arup Laboratories
        11.5.1 Arup Laboratories Company Details
        11.5.2 Arup Laboratories Business Overview
        11.5.3 Arup Laboratories Rare Disease Genetic Testing Introduction
        11.5.4 Arup Laboratories Revenue in Rare Disease Genetic Testing Business (2015-2020)
        11.5.5 Arup Laboratories Recent Development
    11.6 Eurofins Scientific
        11.6.1 Eurofins Scientific Company Details
        11.6.2 Eurofins Scientific Business Overview
        11.6.3 Eurofins Scientific Rare Disease Genetic Testing Introduction
        11.6.4 Eurofins Scientific Revenue in Rare Disease Genetic Testing Business (2015-2020)
        11.6.5 Eurofins Scientific Recent Development
    11.7 Strand Life Sciences
        11.7.1 Strand Life Sciences Company Details
        11.7.2 Strand Life Sciences Business Overview
        11.7.3 Strand Life Sciences Rare Disease Genetic Testing Introduction
        11.7.4 Strand Life Sciences Revenue in Rare Disease Genetic Testing Business (2015-2020)
        11.7.5 Strand Life Sciences Recent Development
    11.8 Ambry Genetics
        11.8.1 Ambry Genetics Company Details
        11.8.2 Ambry Genetics Business Overview
        11.8.3 Ambry Genetics Rare Disease Genetic Testing Introduction
        11.8.4 Ambry Genetics Revenue in Rare Disease Genetic Testing Business (2015-2020)
        11.8.5 Ambry Genetics Recent Development
    11.9 Perkin Elmer
        11.9.1 Perkin Elmer Company Details
        11.9.2 Perkin Elmer Business Overview
        11.9.3 Perkin Elmer Rare Disease Genetic Testing Introduction
        11.9.4 Perkin Elmer Revenue in Rare Disease Genetic Testing Business (2015-2020)
        11.9.5 Perkin Elmer Recent Development
    11.10 Macrogen
        11.10.1 Macrogen Company Details
        11.10.2 Macrogen Business Overview
        11.10.3 Macrogen Rare Disease Genetic Testing Introduction
        11.10.4 Macrogen Revenue in Rare Disease Genetic Testing Business (2015-2020)
        11.10.5 Macrogen Recent Development
    11.11 Baylor Genetics
        10.11.1 Baylor Genetics Company Details
        10.11.2 Baylor Genetics Business Overview
        10.11.3 Baylor Genetics Rare Disease Genetic Testing Introduction
        10.11.4 Baylor Genetics Revenue in Rare Disease Genetic Testing Business (2015-2020)
        10.11.5 Baylor Genetics Recent Development
    11.12 Color Genomics
        10.12.1 Color Genomics Company Details
        10.12.2 Color Genomics Business Overview
        10.12.3 Color Genomics Rare Disease Genetic Testing Introduction
        10.12.4 Color Genomics Revenue in Rare Disease Genetic Testing Business (2015-2020)
        10.12.5 Color Genomics Recent Development
    11.13 Preventiongenetics
        10.13.1 Preventiongenetics Company Details
        10.13.2 Preventiongenetics Business Overview
        10.13.3 Preventiongenetics Rare Disease Genetic Testing Introduction
        10.13.4 Preventiongenetics Revenue in Rare Disease Genetic Testing Business (2015-2020)
        10.13.5 Preventiongenetics Recent Development
    11.14 Progenity
        10.14.1 Progenity Company Details
        10.14.2 Progenity Business Overview
        10.14.3 Progenity Rare Disease Genetic Testing Introduction
        10.14.4 Progenity Revenue in Rare Disease Genetic Testing Business (2015-2020)
        10.14.5 Progenity Recent Development
    11.15 Coopersurgical
        10.15.1 Coopersurgical Company Details
        10.15.2 Coopersurgical Business Overview
        10.15.3 Coopersurgical Rare Disease Genetic Testing Introduction
        10.15.4 Coopersurgical Revenue in Rare Disease Genetic Testing Business (2015-2020)
        10.15.5 Coopersurgical Recent Development
    11.16 Fulgent Genetics
        10.16.1 Fulgent Genetics Company Details
        10.16.2 Fulgent Genetics Business Overview
        10.16.3 Fulgent Genetics Rare Disease Genetic Testing Introduction
        10.16.4 Fulgent Genetics Revenue in Rare Disease Genetic Testing Business (2015-2020)
        10.16.5 Fulgent Genetics Recent Development
    11.17 Myriad Genetics
        10.17.1 Myriad Genetics Company Details
        10.17.2 Myriad Genetics Business Overview
        10.17.3 Myriad Genetics Rare Disease Genetic Testing Introduction
        10.17.4 Myriad Genetics Revenue in Rare Disease Genetic Testing Business (2015-2020)
        10.17.5 Myriad Genetics Recent Development
    11.18 LabCorp
        10.18.1 LabCorp Company Details
        10.18.2 LabCorp Business Overview
        10.18.3 LabCorp Rare Disease Genetic Testing Introduction
        10.18.4 LabCorp Revenue in Rare Disease Genetic Testing Business (2015-2020)
        10.18.5 LabCorp Recent Development
    11.19 Opko Health
        10.19.1 Opko Health Company Details
        10.19.2 Opko Health Business Overview
        10.19.3 Opko Health Rare Disease Genetic Testing Introduction
        10.19.4 Opko Health Revenue in Rare Disease Genetic Testing Business (2015-2020)
        10.19.5 Opko Health Recent Development

12Analyst's Viewpoints/Conclusions

13Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables Table 1. Global Rare Disease Genetic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 3. Key Players of Next-Generation Sequencing (NGS) Table 4. Key Players of Array Technology Table 5. Key Players of PCR-based Testing Table 6. Key Players of Fluorescence in Situ Hybridization (FISH) Table 7. Key Players of Sanger Sequencing Table 8. Key Players of Karyotyping Table 9. Key Players of Others Table 10. Global Rare Disease Genetic Testing Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 11. Global Rare Disease Genetic Testing Market Size by Regions (US$ Million): 2020 VS 2026 Table 12. Global Rare Disease Genetic Testing Market Size by Regions (2015-2020) (US$ Million) Table 13. Global Rare Disease Genetic Testing Market Share by Regions (2015-2020) Table 14. Global Rare Disease Genetic Testing Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 15. Global Rare Disease Genetic Testing Market Share by Regions (2021-2026) Table 16. Rare Disease Genetic Testing Market Market Trends Table 17. Rare Disease Genetic Testing Market Drivers Table 18. Rare Disease Genetic Testing Market Challenges Table 19. Rare Disease Genetic Testing Market Restraints Table 20. Global Rare Disease Genetic Testing Revenue by Players (2015-2020) (US$ Million) Table 21. Global Rare Disease Genetic Testing Market Share by Players (2015-2020) Table 22. Global Top Rare Disease Genetic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rare Disease Genetic Testing as of 2019) Table 23. Global Rare Disease Genetic Testing by Players Market Concentration Ratio (CR5 and HHI) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Rare Disease Genetic Testing Product Solution and Service Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Rare Disease Genetic Testing Market Size by Type (2015-2020) (US$ Million) Table 28. Global Rare Disease Genetic Testing Market Size Share by Type (2015-2020) Table 29. Global Rare Disease Genetic Testing Revenue Market Share by Type (2021-2026) Table 30. Global Rare Disease Genetic Testing Market Size Share by Application (2015-2020) Table 31. Global Rare Disease Genetic Testing Market Size by Application (2015-2020) (US$ Million) Table 32. Global Rare Disease Genetic Testing Market Size Share by Application (2021-2026) Table 33. North America Rare Disease Genetic Testing Market Size by Type (2015-2020) (US$ Million) Table 34. North America Rare Disease Genetic Testing Market Share by Type (2015-2020) Table 35. North America Rare Disease Genetic Testing Market Size by Application (2015-2020) (US$ Million) Table 36. North America Rare Disease Genetic Testing Market Share by Application (2015-2020) Table 37. North America Rare Disease Genetic Testing Market Size by Country (US$ Million) (2015-2020) Table 38. North America Rare Disease Genetic Testing Market Share by Country (2015-2020) Table 39. Europe Rare Disease Genetic Testing Market Size by Type (2015-2020) (US$ Million) Table 40. Europe Rare Disease Genetic Testing Market Share by Type (2015-2020) Table 41. Europe Rare Disease Genetic Testing Market Size by Application (2015-2020) (US$ Million) Table 42. Europe Rare Disease Genetic Testing Market Share by Application (2015-2020) Table 43. Europe Rare Disease Genetic Testing Market Size by Country (US$ Million) (2015-2020) Table 44. Europe Rare Disease Genetic Testing Market Share by Country (2015-2020) Table 45. China Rare Disease Genetic Testing Market Size by Type (2015-2020) (US$ Million) Table 46. China Rare Disease Genetic Testing Market Share by Type (2015-2020) Table 47. China Rare Disease Genetic Testing Market Size by Application (2015-2020) (US$ Million) Table 48. China Rare Disease Genetic Testing Market Share by Application (2015-2020) Table 49. China Rare Disease Genetic Testing Market Size by Region (US$ Million) (2015-2020) Table 50. China Rare Disease Genetic Testing Market Share by Region (2015-2020) Table 51. Japan Rare Disease Genetic Testing Market Size by Type (2015-2020) (US$ Million) Table 52. Japan Rare Disease Genetic Testing Market Share by Type (2015-2020) Table 53. Japan Rare Disease Genetic Testing Market Size by Application (2015-2020) (US$ Million) Table 54. Japan Rare Disease Genetic Testing Market Share by Application (2015-2020) Table 55. Japan Rare Disease Genetic Testing Market Size by Country (US$ Million) (2015-2020) Table 56. Japan Rare Disease Genetic Testing Market Share by Country (2015-2020) Table 57. Southeast Asia Rare Disease Genetic Testing Market Size by Type (2015-2020) (US$ Million) Table 58. Southeast Asia Rare Disease Genetic Testing Market Share by Type (2015-2020) Table 59. Southeast Asia Rare Disease Genetic Testing Market Size by Application (2015-2020) (US$ Million) Table 60. Southeast Asia Rare Disease Genetic Testing Market Share by Application (2015-2020) Table 61. Southeast Asia Rare Disease Genetic Testing Market Size by Country (US$ Million) (2015-2020) Table 62. Southeast Asia Rare Disease Genetic Testing Market Share by Country (2015-2020) Table 63. Quest Diagnostics Company Details Table 64. Quest Diagnostics Business Overview Table 65. Quest Diagnostics Product Table 66. Quest Diagnostics Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million) Table 67. Quest Diagnostics Recent Development Table 68. Centogene Company Details Table 69. Centogene Business Overview Table 70. Centogene Product Table 71. Centogene Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million) Table 72. Centogene Recent Development Table 73. Invitae Corporation Company Details Table 74. Invitae Corporation Business Overview Table 75. Invitae Corporation Product Table 76. Invitae Corporation Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million) Table 77. Invitae Corporation Recent Development Table 78. 3billion Company Details Table 79. 3billion Business Overview Table 80. 3billion Product Table 81. 3billion Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million) Table 82. 3billion Recent Development Table 83. Arup Laboratories Company Details Table 84. Arup Laboratories Business Overview Table 85. Arup Laboratories Product Table 86. Arup Laboratories Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million) Table 87. Arup Laboratories Recent Development Table 88. Eurofins Scientific Company Details Table 89. Eurofins Scientific Business Overview Table 90. Eurofins Scientific Product Table 91. Eurofins Scientific Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million) Table 92. Eurofins Scientific Recent Development Table 93. Strand Life Sciences Company Details Table 94. Strand Life Sciences Business Overview Table 95. Strand Life Sciences Product Table 96. Strand Life Sciences Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million) Table 97. Strand Life Sciences Recent Development Table 98. Ambry Genetics Business Overview Table 99. Ambry Genetics Product Table 100. Ambry Genetics Company Details Table 101. Ambry Genetics Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million) Table 102. Ambry Genetics Recent Development Table 103. Perkin Elmer Company Details Table 104. Perkin Elmer Business Overview Table 105. Perkin Elmer Product Table 106. Perkin Elmer Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million) Table 107. Perkin Elmer Recent Development Table 108. Macrogen Company Details Table 109. Macrogen Business Overview Table 110. Macrogen Product Table 111. Macrogen Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million) Table 112. Macrogen Recent Development Table 113. Baylor Genetics Company Details Table 114. Baylor Genetics Business Overview Table 115. Baylor Genetics Product Table 116. Baylor Genetics Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million) Table 117. Baylor Genetics Recent Development Table 118. Color Genomics Company Details Table 119. Color Genomics Business Overview Table 120. Color Genomics Product Table 121. Color Genomics Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million) Table 122. Color Genomics Recent Development Table 123. Preventiongenetics Company Details Table 124. Preventiongenetics Business Overview Table 125. Preventiongenetics Product Table 126. Preventiongenetics Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million) Table 127. Preventiongenetics Recent Development Table 128. Progenity Company Details Table 129. Progenity Business Overview Table 130. Progenity Product Table 131. Progenity Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million) Table 132. Progenity Recent Development Table 133. Coopersurgical Company Details Table 134. Coopersurgical Business Overview Table 135. Coopersurgical Product Table 136. Coopersurgical Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million) Table 137. Coopersurgical Recent Development Table 138. Fulgent Genetics Company Details Table 139. Fulgent Genetics Business Overview Table 140. Fulgent Genetics Product Table 141. Fulgent Genetics Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million) Table 142. Fulgent Genetics Recent Development Table 143. Myriad Genetics Company Details Table 144. Myriad Genetics Business Overview Table 145. Myriad Genetics Product Table 146. Myriad Genetics Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million) Table 147. Myriad Genetics Recent Development Table 148. LabCorp Company Details Table 149. LabCorp Business Overview Table 150. LabCorp Product Table 151. LabCorp Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million) Table 152. LabCorp Recent Development Table 153. Opko Health Company Details Table 154. Opko Health Business Overview Table 155. Opko Health Product Table 156. Opko Health Revenue in Rare Disease Genetic Testing Business (2015-2020) (US$ Million) Table 157. Opko Health Recent Development Table 158. Research Programs/Design for This Report Table 159. Key Data Information from Secondary Sources Table 160. Key Data Information from Primary Sources List of Figures Figure 1. Global Rare Disease Genetic Testing Market Share by Type: 2020 VS 2026 Figure 2. Next-Generation Sequencing (NGS) Features Figure 3. Array Technology Features Figure 4. PCR-based Testing Features Figure 5. Fluorescence in Situ Hybridization (FISH) Features Figure 6. Sanger Sequencing Features Figure 7. Karyotyping Features Figure 8. Others Features Figure 9. Global Rare Disease Genetic Testing Market Share by Application: 2020 VS 2026 Figure 10. Research Laboratories and CROs Case Studies Figure 11. Diagnostic Laboratories Case Studies Figure 12. Hospitals and Clinics Case Studies Figure 13. Others Case Studies Figure 14. Rare Disease Genetic Testing Report Years Considered Figure 15. Global Rare Disease Genetic Testing Market Size (US$ Million), YoY Growth 2015-2026 Figure 16. Global Rare Disease Genetic Testing Market Share by Regions: 2020 VS 2026 Figure 17. Global Rare Disease Genetic Testing Market Share by Regions (2021-2026) Figure 18. Global Rare Disease Genetic Testing Market Share by Players in 2019 Figure 19. Global Top Rare Disease Genetic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rare Disease Genetic Testing as of 2019 Figure 20. The Top 10 and 5 Players Market Share by Rare Disease Genetic Testing Revenue in 2019 Figure 21. North America Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. United States Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. Canada Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. Europe Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Germany Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. France Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. U.K. Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. Italy Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. Russia Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. Nordic Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. Rest of Europe Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. Asia-Pacific Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. China Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Japan Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. South Korea Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Southeast Asia Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. India Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Australia Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Rest of Asia-Pacific Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Latin America Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. Mexico Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Brazil Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 43. Middle East & Africa Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 44. Turkey Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 45. Saudi Arabia Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 46. UAE Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 47. Rest of Middle East & Africa Rare Disease Genetic Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 48. Quest Diagnostics Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020) Figure 49. Centogene Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020) Figure 50. Invitae Corporation Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020) Figure 51. 3billion Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020) Figure 52. Arup Laboratories Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020) Figure 53. Eurofins Scientific Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020) Figure 54. Strand Life Sciences Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020) Figure 55. Ambry Genetics Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020) Figure 56. Perkin Elmer Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020) Figure 57. Macrogen Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020) Figure 58. Baylor Genetics Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020) Figure 59. Color Genomics Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020) Figure 60. Preventiongenetics Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020) Figure 61. Progenity Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020) Figure 62. Coopersurgical Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020) Figure 63. Fulgent Genetics Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020) Figure 64. Myriad Genetics Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020) Figure 65. LabCorp Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020) Figure 66. Opko Health Revenue Growth Rate in Rare Disease Genetic Testing Business (2015-2020) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New IT and Telecommunications Reports

SerDes Market Research Report 2025

As per credible projections, SerDes market is presumed to expand with a CAGR of 9.3% between 2020 and 2025, hence amassing USD 707.4 million by the year 2025. Rising integration of technologically advanced communication systems across various industr...

Global Foundry Service Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Market Overview The global Foundry Service market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.7% in the forecast period of 2020 to 2025 and will expected to reach USD 66930 million by 2025, from US...

Global Full Service Long Term Material Handling Equipment Rental Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Market Overview The global Full Service Long Term Material Handling Equipment Rental market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to...

Global Full Service Long Term Earthmoving Equipment Rental Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Market Overview The global Full Service Long Term Earthmoving Equipment Rental market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach...

Global Food Logistics Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Market Overview The global Food Logistics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.4% in the forecast period of 2020 to 2025 and will expected to reach USD 105320 million by 2025, from US...

Other Reports by QY Research

Global Real-time Production Monitoring Software Market Size, Status and Forecast 2020-2026

Real-time Production Monitoring Software market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Real-time Production Monitoring Software market will be able to gain the upper hand as they use the ...

Global Automotive Acoustic Insulation Materials Market Insights and Forecast to 2026

Automotive Acoustic Insulation Materials market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Automotive Acoustic Insulation Materials market will be able to gain the upper hand as they use the ...

Global Kvass Market Insights and Forecast to 2026

Kvass market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Kvass market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales...

Global Trailer Tire Inflation Systems Market Insights and Forecast to 2026

Trailer Tire Inflation Systems market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Trailer Tire Inflation Systems market will be able to gain the upper hand as they use the report as a powerful...

Global Lipgloss Market Insights and Forecast to 2026

Lipgloss market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lipgloss market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on...

Publisher: QY Research
Chat with us